AstraZeneca PLC
1331,00
24-апреля-25 08:51:57
15 мин. задержка
Акции
+5,00
+0,38%
Сегодняшний диапазон
1319,50 - 1334,00
ISIN
N/A
Источник
Cboe
- Котировки
- Графики
Новости
- Статистика
-
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
25 апр 2024 12:52:49 Источник NASDAQ US Markets
-
25 апр 2024 11:30:48 Источник NASDAQ US Markets
-
25 апр 2024 11:15:48 Источник NASDAQ Stocks
-
AstraZeneca Q1 Profit, Revenues Climb; Backs FY24 Outlook
25 апр 2024 03:16:35 Источник NASDAQ US Markets
-
ANGLE Reaches Deal With AstraZeneca To Advance DDR Assay For Circulating Tumor Cell Detection
24 апр 2024 03:37:17 Источник NASDAQ US Markets
-
FDA Approves AstraZeneca And Daiichi Sankyo's Enhertu For Solid Tumors Treatment
05 апр 2024 22:16:14 Источник NASDAQ US Markets
-
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
05 апр 2024 09:38:12 Источник NASDAQ Stocks
-
AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
02 апр 2024 10:15:53 Источник NASDAQ Stocks
-
Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock
26 мар 2024 18:07:03 Источник NASDAQ Stocks
-
AstraZeneca Announces FDA Approval For Ultomiris - Quick Facts
25 мар 2024 03:55:20 Источник NASDAQ US Markets
-
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
20 мар 2024 14:32:29 Источник NASDAQ Stocks
-
AstraZeneca To Buy Fusion Pharma For Up To $2.4 Bln
19 мар 2024 03:31:51 Источник NASDAQ US Markets
-
AstraZeneca To Expand Savings Programs For US Inhaled Respiratory Portfolio
18 мар 2024 07:40:23 Источник NASDAQ US Markets
-
First Week of AZN May 17th Options Trading
15 мар 2024 12:39:15 Источник NASDAQ Stocks
-
AstraZeneca To Buy Amolyt Pharma For Up To $1.05 Bln To Expand Late-stage Rare Disease Pipeline
14 мар 2024 03:46:14 Источник NASDAQ US Markets
-
AstraZeneca Announces Initiation Of Phase III Trial With BREZTRI
13 мар 2024 07:41:44 Источник NASDAQ US Markets
-
AZN Crosses Above Key Moving Average Level
11 мар 2024 16:51:21 Источник NASDAQ US Markets
-
AZN Crosses Above Key Moving Average Level
11 мар 2024 16:44:19 Источник NASDAQ Stocks
-
AstraZeneca's Datopotamab Deruxtecan Applications Validated In EU For Lung Cancer, Breast Cancer
04 мар 2024 03:26:38 Источник NASDAQ US Markets
-
AstraZeneca: Voydeya Recommended For Approval In The EU By CHMP - Quick Facts
26 фев 2024 02:56:02 Источник NASDAQ US Markets